<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00016523</url>
  </required_header>
  <id_info>
    <org_study_id>NICHD-NRN-0026</org_study_id>
    <secondary_id>U10HD034216</secondary_id>
    <secondary_id>M01RR000032</secondary_id>
    <secondary_id>U10HD027904</secondary_id>
    <secondary_id>U10HD027853</secondary_id>
    <secondary_id>M01RR008084</secondary_id>
    <secondary_id>U10HD027856</secondary_id>
    <secondary_id>M01RR000750</secondary_id>
    <secondary_id>U10HD021397</secondary_id>
    <secondary_id>M01RR016587</secondary_id>
    <secondary_id>U10HD027880</secondary_id>
    <secondary_id>M01RR000070</secondary_id>
    <secondary_id>U10HD040689</secondary_id>
    <secondary_id>M01RR000633</secondary_id>
    <secondary_id>U10HD021373</secondary_id>
    <secondary_id>U10HD021385</secondary_id>
    <secondary_id>U10HD027871</secondary_id>
    <secondary_id>M01RR006022</secondary_id>
    <secondary_id>U10HD040498</secondary_id>
    <secondary_id>M01RR007122</secondary_id>
    <secondary_id>U10HD040461</secondary_id>
    <secondary_id>U10HD040521</secondary_id>
    <secondary_id>M01RR000044</secondary_id>
    <nct_id>NCT00016523</nct_id>
  </id_info>
  <brief_title>Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure</brief_title>
  <acronym>Preemie iNO</acronym>
  <official_title>Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NICHD Neonatal Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>NICHD Neonatal Research Network</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multicenter trial tested whether inhaled nitric oxide would reduce death or the need for
      oxygen in preterm infants (less than 34 weeks gestational age) with severe lung disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This multicenter, randomized, double-masked, controlled clinical trial evaluated the efficacy
      of inhaled nitric oxide (iNO) in the treatment of the preterm infant with respiratory failure
      secondary to respiratory distress syndrome (RDS), sepsis/pneumonia, aspiration syndrome,
      idiopathic pulmonary hypertension and/or suspected pulmonary hypoplasia.

      Infants were followed until death or discharge to home. The trial compared iNO therapy to
      mock gas delivery as the control, and otherwise incorporated conventional management
      strategies (including treatment with surfactant and high frequency ventilation as adjuncts to
      iNO therapy).

      During the initial dosing, iNO was started at 5 ppm and could be increased to 10 ppm. If the
      infant did not respond, study gas was discontinued. For infants who responded to study gas, a
      gradual weaning was initiated. The total exposure to study gas did not exceed 336 hours (14
      days). Infants were monitored for signs of toxicity.

      Medical and neurodevelopmental outcome of surviving infants were assessed at 18 to 22 months
      corrected age by masked, certified examiners.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Preliminary results showed increased intraventricular hemorrhage (IVH) in experimental arm
  </why_stopped>
  <start_date>January 2001</start_date>
  <completion_date type="Actual">May 2006</completion_date>
  <primary_completion_date type="Actual">September 2003</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Death or Bronchopulmonary Dysplasia</measure>
    <time_frame>At 36 weeks post-conceptional age</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraventricular Hemorrhage Grade III and IV</measure>
    <time_frame>At 36 weeks post-conceptional age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days on assisted ventilation</measure>
    <time_frame>At 36 weeks post-conceptional age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinopathy of prematurity</measure>
    <time_frame>At hospital discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Air leaks</measure>
    <time_frame>At 36 weeks post-conceptual age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days on oxygen</measure>
    <time_frame>At 36 weeks post-conceptual age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Supplemental oxygen</measure>
    <time_frame>At 36 weeks post-conceptual age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurodevelopmental outcome</measure>
    <time_frame>18-22 months corrected age</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">420</enrollment>
  <condition>Infant, Newborn</condition>
  <condition>Infant, Low Birth Weight</condition>
  <condition>Infant, Small for Gestational Age</condition>
  <condition>Infant, Premature</condition>
  <condition>Respiratory Distress Syndrome (RDS)</condition>
  <condition>Sepsis</condition>
  <condition>Pneumonia</condition>
  <condition>Hypertension, Pulmonary</condition>
  <arm_group>
    <arm_group_label>Inhaled Nitric Oxide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inhaled Nitric Oxide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Inhaled Oxygen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhaled nitric oxide</intervention_name>
    <description>Started at 5 ppm and could be increased to 10 ppm</description>
    <arm_group_label>Inhaled Nitric Oxide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Started at 5 ppm and could be increased to 10 ppm</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Any infant with a birth weight 401 - 1500 grams and &lt; 34 weeks gestational age with an
             OI (mean Paw x FiO2 x 100/PaO2) &gt; 10 on two consecutive blood gases at least 30
             minutes apart, but no more than 12 hours apart.

        or

          -  Infants &gt; 1500 grams and &lt; 34 weeks gestational age will be entered in the Larger
             Preemie Pilot Study if they have an OI greater than or equal to 15 on two consecutive
             blood gases at least 30 minutes apart, but no more than 12 hours apart.

          -  Infants requiring assisted ventilation with a diagnosis of RDS/HMD, pneumonia and/or
             sepsis, aspiration syndrome, idiopathic pulmonary hypertension, or suspected pulmonary
             hypoplasia associated with PROM and/or oligohydramnios.

          -  Greater than or equal to 4 hours after one dose of surfactant.

          -  Less than or equal to 120 hours of age.

          -  All infants must have an indwelling arterial line.

        Exclusion Criteria

          -  Any infant in whom a decision has been made not to provide full treatment (e.g.
             chromosomal anomalies or severe birth asphyxia).

          -  Known structural congenital heart disease, except patent ductus arteriosus and
             atrial-level shunts.

          -  Infants with any major abnormality involving the respiratory system such as congenital
             diaphragmatic hernia, tracheoesophageal fistula or cystic fibrosis.

          -  Any bleeding diathesis considered to be clinically significant or thrombocytopenia
             with platelet count &lt; 50,000.

          -  Prior enrollment into a conflicting clinical trial such as the Neonatal Network
             Surfactant CPAP trial.Inclusion Criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>120 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krisa P. Van Meurs, MD</last_name>
    <role>Study Director</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Waldemar A. Carlo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abbot R. Laptook, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brown University, Women &amp; Infants Hospital of Rhode Island</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Edward F. Donovan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James A. Lemons, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shahnaz Duara, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Charles R. Rosenfeld, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas, Southwestern Medical Center at Dallas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jon E. Tyson, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seetha Shankaran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wayne State University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard A. Ehrenkranz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>T. Michael O'Shea, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neil N. Finer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dale L. Phelps, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark L. Hudak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robin H. Steinhorn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>G. Ganesh Konduri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical College of Wisconsin, Milwaukee</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California at San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103-8774</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>RTI International</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brown University, Women &amp; Infants Hospital of Rhode Island</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://neonatal.rti.org</url>
    <description>NICHD Neonatal Research Network</description>
  </link>
  <link>
    <url>http://www.nichd.nih.gov/cochrane/Barrington5/BARRINGTON5.HTM</url>
    <description>Cochrane meta-analyses: &quot;Inhaled nitric oxide for respiratory failure in preterm infants&quot;</description>
  </link>
  <reference>
    <citation>Sokol GM, Ehrenkranz RA. Inhaled nitric oxide therapy in neonatal hypoxic respiratory failure: insights beyond primary outcomes. Semin Perinatol. 2003 Aug;27(4):311-9. Review.</citation>
    <PMID>14510322</PMID>
  </reference>
  <results_reference>
    <citation>Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, Perritt R, Higgins RD, Oh W, Hudak ML, Laptook AR, Shankaran S, Finer NN, Carlo WA, Kennedy KA, Fridriksson JH, Steinhorn RH, Sokol GM, Konduri GG, Aschner JL, Stoll BJ, D'Angio CT, Stevenson DK; Preemie Inhaled Nitric Oxide Study. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med. 2005 Jul 7;353(1):13-22.</citation>
    <PMID>16000352</PMID>
  </results_reference>
  <results_reference>
    <citation>Van Meurs KP, Hintz SR, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, Perritt R, Das A, Higgins RD, Stevenson DK. Inhaled nitric oxide in infants &gt;1500 g and &lt;34 weeks gestation with severe respiratory failure. J Perinatol. 2007 Jun;27(6):347-52. Epub 2007 Apr 19.</citation>
    <PMID>17443204</PMID>
  </results_reference>
  <results_reference>
    <citation>Hintz SR, Slovis T, Bulas D, Van Meurs KP, Perritt R, Stevenson DK, Poole WK, Das A, Higgins RD; NICHD Neonatal Research Network. Interobserver reliability and accuracy of cranial ultrasound scanning interpretation in premature infants. J Pediatr. 2007 Jun;150(6):592-6, 596.e1-5.</citation>
    <PMID>17517240</PMID>
  </results_reference>
  <results_reference>
    <citation>Hintz SR, Van Meurs KP, Perritt R, Poole WK, Das A, Stevenson DK, Ehrenkranz RA, Lemons JA, Vohr BR, Heyne R, Childers DO, Peralta-Carcelen M, Dusick A, Johnson YR, Morris B, Dillard R, Vaucher Y, Steichen J, Adams-Chapman I, Konduri G, Myers GJ, de Ungria M, Tyson JE, Higgins RD; NICHD Neonatal Research Network. Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized controlled trial of inhaled nitric oxide. J Pediatr. 2007 Jul;151(1):16-22, 22.e1-3.</citation>
    <PMID>17586184</PMID>
  </results_reference>
  <results_reference>
    <citation>Ambalavanan N, Van Meurs KP, Perritt R, Carlo WA, Ehrenkranz RA, Stevenson DK, Lemons JA, Poole WK, Higgins RD; NICHD Neonatal Research Network, Bethesda, MD. Predictors of death or bronchopulmonary dysplasia in preterm infants with respiratory failure. J Perinatol. 2008 Jun;28(6):420-6. doi: 10.1038/jp.2008.18. Epub 2008 Mar 13.</citation>
    <PMID>18337740</PMID>
  </results_reference>
  <results_reference>
    <citation>Chock VY, Van Meurs KP, Hintz SR, Ehrenkranz RA, Lemons JA, Kendrick DE, Stevenson DK; NICHD Neonatal Research Network. Inhaled nitric oxide for preterm premature rupture of membranes, oligohydramnios, and pulmonary hypoplasia. Am J Perinatol. 2009 Apr;26(4):317-22. doi: 10.1055/s-0028-1104743. Epub 2008 Dec 9.</citation>
    <PMID>19067285</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2001</study_first_submitted>
  <study_first_submitted_qc>May 15, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2001</study_first_posted>
  <last_update_submitted>September 22, 2017</last_update_submitted>
  <last_update_submitted_qc>September 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <name_title>Krisa P. Van Meurs, MD, Lead Principal Investigator</name_title>
    <organization>Stanford University</organization>
  </responsible_party>
  <keyword>NICHD Neonatal Research Network</keyword>
  <keyword>Extremely Low Birth Weight (ELBW)</keyword>
  <keyword>Very Low Birth Weight (VLBW)</keyword>
  <keyword>Prematurity</keyword>
  <keyword>Inhaled nitric oxide</keyword>
  <keyword>Aspiration syndrome</keyword>
  <keyword>Idiopathic pulmonary hypertension</keyword>
  <keyword>Pulmonary hypoplasia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

